Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

SkinHealth Systems Q3 2026 Results: Net Loss of $888K, Loss Narrows

SkinHealth Systems Inc. reported a net loss of $0.9 million for the third quarter of 2026, an improvement from an $11.0 million loss in the prior year period, driven by reduced operating expenses. Total assets decreased significantly from $499.8 million at year-end 2025 to $389.1 million as of September 30, 2026, primarily due to a reduction in cash used for the repayment and repurchase of convertible senior notes.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue69.270.7
Gross profit47.145.6
Profit before tax-0.1-10.6
Net income-0.9-11.0
EPS (diluted, $ a share)$-0.14$-1.74

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year-2.1%
Gross margin68.2%
Operating margin7.2%
Source

10-Q filed with the SEC, NASDAQ: SKIN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

SkinHealth Systems Inc.: key numbers

Share price
$15.05Close, Nov 16
Market cap
$98.5M
Shares outstanding
6.54MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from SkinHealth Systems Inc.

All →
4:18 PM ET 8-K
Financial Results

SkinHealth Systems Financial Results

SkinHealth Systems reported third quarter 2026 financial results, with net sales of $69.2 million and a significantly narrowed net loss of $0.9 million compared to $11.0 million in the prior year. The company highlighted a return to growth in consumables and improved adjusted EBITDA margins as it executes on strategic priorities for its flagship Hydrafacial brand.

Term
Q3 2026

“Our third quarter results reflect encouraging progress in strengthening our business. Revenue trends improved, consumables returned to growth, and we delivered healthy adjusted EBITDA performance. While we have more work ahead, these results give us greater confidence that the actions we are taking are moving the business in the right direction.”

Pedro Malha, President and Chief Executive Officer
9:16 AM ET 8-K
Reverse Stock Split

SkinHealth Systems Reverse Stock Split

SkinHealth Systems Inc. implemented a 1-for-20 reverse stock split of its Class A Common Stock, effective October 14, 2026. The action is intended to help the company regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces the outstanding share count from approximately 130.3 million to 6.5 million shares.

4:06 PM ET 8-K
Loan & Debt

SkinHealth Systems $103M Debt Financing with U.S. Bank National Association

SkinHealth Systems Inc. repaid in full the remaining $103.2 million aggregate principal amount of its 1.25% Convertible Senior Notes due 2026. Following the payment of principal and accrued interest, the related indenture was satisfied and discharged, releasing the company from its obligations under the notes.

Value
$103M
Counterparty
U.S. Bank National Association
4:06 PM ET 8-K
Reverse Stock Split

SkinHealth Systems Reverse Stock Split

SkinHealth Systems stockholders approved an amendment to the company's Restated Certificate of Incorporation to implement a reverse stock split of its Class A Common Stock. The approved ratio range is between 1-for-5 and 1-for-20, with the final ratio to be determined by the board of directors.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.